<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Medicine</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-0245</issn><issn publication-format="electronic">2313-0261</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">47652</article-id><article-id pub-id-type="doi">10.22363/2313-0245-2025-29-4-510-519</article-id><article-id pub-id-type="edn">ALZJSI</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DENTISTRY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>СТОМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Oral microbiota importance in the development and prognosis of oropharyngeal region oncological diseases</article-title><trans-title-group xml:lang="ru"><trans-title>Значение микробиоты полости рта в возникновении и прогнозе онкологических заболеваний орофарингеальной области</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4068-7698</contrib-id><contrib-id contrib-id-type="spin">7091-8276</contrib-id><name-alternatives><name xml:lang="en"><surname>Avanesov</surname><given-names>Anatoliy M.</given-names></name><name xml:lang="ru"><surname>Аванесов</surname><given-names>А. М.</given-names></name></name-alternatives><email>Simionidi_e@pfur.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8037-594X</contrib-id><contrib-id contrib-id-type="spin">2562-4392</contrib-id><name-alternatives><name xml:lang="en"><surname>Gvozdikova</surname><given-names>Evgeniya N.</given-names></name><name xml:lang="ru"><surname>Гвоздикова</surname><given-names>Е. Н.</given-names></name></name-alternatives><email>Simionidi_e@pfur.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-6388-5261</contrib-id><contrib-id contrib-id-type="spin">3974-2021</contrib-id><name-alternatives><name xml:lang="en"><surname>Simionidi</surname><given-names>Yefi</given-names></name><name xml:lang="ru"><surname>Симиониди</surname><given-names>Е.</given-names></name></name-alternatives><email>Simionidi_e@pfur.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5426-1084</contrib-id><contrib-id contrib-id-type="spin">9410-6747</contrib-id><name-alternatives><name xml:lang="en"><surname>Titova</surname><given-names>Vera A.</given-names></name><name xml:lang="ru"><surname>Титова</surname><given-names>В. А.</given-names></name></name-alternatives><email>Simionidi_e@pfur.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">RUDN University</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Russian Scientific Center of Roentgenoradiology</institution></aff><aff><institution xml:lang="ru">Российский научный центр рентгенорадиологии</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-12-18" publication-format="electronic"><day>18</day><month>12</month><year>2025</year></pub-date><volume>29</volume><issue>4</issue><issue-title xml:lang="en">MEDICAL GENETICS</issue-title><issue-title xml:lang="ru">МЕДИЦИНСКАЯ ГЕНЕТИКА</issue-title><fpage>510</fpage><lpage>519</lpage><history><date date-type="received" iso-8601-date="2025-12-17"><day>17</day><month>12</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Avanesov A.M., Gvozdikova E.N., Simionidi Y., Titova V.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Аванесов А.М., Гвоздикова Е.Н., Симиониди Е., Титова В.А.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Avanesov A.M., Gvozdikova E.N., Simionidi Y., Titova V.A.</copyright-holder><copyright-holder xml:lang="ru">Аванесов А.М., Гвоздикова Е.Н., Симиониди Е., Титова В.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/medicine/article/view/47652">https://journals.rudn.ru/medicine/article/view/47652</self-uri><abstract xml:lang="en"><p>Relevance. Despite many years of scientific research and clinical results, cancer remains a global health problem. In recent years, there has been an increased interest in studying the role of microorganisms in the occurrence, prognosis and progression of cancer. The probability of isolating carcinogenic microorganisms in the oral microbiota is quite high. In this regard, understanding the role of microorganisms in the occurrence and course of cancer pathology in the future can contribute to the development of innovative strategies for the prevention, treatment of malignant neoplasms and minimization of complications of antitumor treatment. The purpose of this review is a literature analysis of the relationship between representatives of the human oral microbiota in the occurrence and prognosis of cancer. Collection and analysis of 1050 scientific papers using PubMed, Google Scholar and eLIBRARY search engines, published from 2003 to 2024, of which 47 papers are included in this literature review. According to the literature analysis, prevention, diagnostics and treatment of oncological diseases can and should be supplemented by dental approaches aimed at normalizing the microflora. Understanding that oral sanitation significantly reduces its bacterial contamination and, as a result, reduces the number of pathogenic and oncogenic microorganisms can improve the quality of antitumor treatment without significant material and social costs. Conclusion. The use of modern methods of diagnostics and monitoring of oral microbiota in dentistry can become the basis for the development of new strategies for the prevention and treatment of malignant neoplasms of the oral mucosa. Integration of these data into clinical practice requires interdisciplinary cooperation between oncologists, microbiologists and dentists to improve the prognosis of patient treatment.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность. Несмотря на многолетние научные исследования и клинические результаты, онкологические заболевания остаются глобальной проблемой здравоохранения. В последние годы возрос интерес к изучению роли микроорганизмов в возникновении, прогнозе и прогрессировании онкологических заболеваний. Вероятность выделения в составе ротовой микробиоты канцерогенных микроорганизмов достаточно велика. В связи с этим, понимание роли микроорганизмов в возникновении и течении онкологической патологии в дальнейшем может способствовать разработке инновационных стратегий профилактики, лечения злокачественных новообразований и минимизации осложнений противоопухолевого лечения. Целью данного обзора является литературный анализ роли представителей микробиоты полости рта человека в возникновении и прогнозе онкологических заболеваний. В ходе исследования проведены сбор и анализ 1050 научных работ с помощью поисковых систем PubMed, Google Scholar и eLIBRARY, опубликованных с 2003 по 2024 гг., среди которых 47 работ включены в данный литературный обзор. Согласно данным проведенного литературного анализа, профилактика, диагностика и лечение онкологических заболеваний могут и должны быть дополнены стоматологическими подходами, направленными на нормализацию микробиоты полости рта. Понимание того, что санация полости рта существенно снижает ее бактериальную обсемененность и как следствие сокращает количество патогенных и онкогенных микроорганизмов, может повысить качество противоопухолевого лечения без существенных материальных и социальных затрат. Выводы. Применение современных методов диагностики и мониторинга микробиоты полости рта в стоматологии может стать основой для разработки новых стратегий профилактики и лечения злокачественных новообразований слизистой оболочки полости рта. Интеграция этих данных в клиническую практику требует междисциплинарного сотрудничества между онкологами, микробиологами и стоматологами для улучшения прогноза лечения пациентов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Microbiota oral cavity</kwd><kwd>malignant neoplasms</kwd><kwd>carcinogenesis</kwd><kwd>oncogenic bacteria</kwd><kwd>chronic inflammation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>микробиота полости рта</kwd><kwd>злокачественные новообразования</kwd><kwd>канцерогенез</kwd><kwd>онкогенные бактерии</kwd><kwd>хроническое воспаление</kwd></kwd-group><funding-group/></article-meta><fn-group/></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Gilbert JA, Neufeld JD. Life in a World without Microbes. PLoS Biol. 2014;12(12): e1002020. doi:10.1371/journal.pbio.1002020</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Hou K, Wu ZX, Chen, XY, Wang, JQ, Zhang D., Xiao C, Zhu D, Koya, J B, Wei L, Li J, Chen ZS. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7(1):135. doi:10.1038/s41392–022–00974–4</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino J F, Patterson PH, Mazmanian S K. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155(7):1451–1463. doi:10.1016/j.cell.2013.11.024</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20(2):159–166. doi:10.1038/nm.3444</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Mesa F, Magan-Fernandez A, Castellino G, Chianetta R, Nibali L, Rizzo M. Periodontitis and mechanisms of cardiometabolic risk: Novel insights and future perspectives. Biochim Biophys Acta Mol Basis Dis. 2019;1865(2):476–484. doi:10.1016/j.bbadis.2018.12.001</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Shi Y, Zheng W, Yang K, Harris KG, Ni K, Xue L, et al. Intratumoral accumulation of gut microbiota facilitates CD47‑based immunotherapy via STING signaling. J Exp Med. 2020;217(5): e20192282. doi:10.1084/jem.20192282</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492–506. doi:10.1038/s41422–020–0332–7</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>González-Sánchez P, DeNicola GM. The microbiome(s) and cancer: know thy neighbor(s). J Pathol. 2021;254(4):332–343. doi:10.1002/path.5661</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70. doi:10.1016/s0092-8674 (00) 81683-9</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Stasiewicz M, Karpiński TM. The oral microbiota and its role in carcinogenesis. Semin Cancer Biol. 2022;86(Pt3):633–642. doi:10.1016/j.semcancer.2021.11.002</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Whiteman DC, Wilson LF. The fractions of cancer attributable to modifiable factors: A global review. Cancer Epidemiol. 2016;44:203–221. doi:10.1016/j.canep.2016.06.013</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Rajagopala SV, Vashee S, Oldfield LM, Suzuki Y, Venter JC, Telenti A, Nelson KE. The Human Microbiome and Cancer. Cancer Prev Res (Phila). 2017;10(4):226–234. doi:10.1158/1940-6207.CAPR‑16-0249</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Bollati V, Monti P, Biganzoli D, Marano G, Favero C, Iodice S, et al. Environmental and Lifestyle Cancer Risk Factors: Shaping Extracellular Vesicle OncomiRs and Paving the Path to Cancer Development. Cancers (Basel). 2023;15(17):4317. doi:10.3390/cancers15174317</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Sun J, Tang Q, Yu S, Xie M, Xie Y, Chen G, Chen L. Role of the oral microbiota in cancer evolution and progression. Cancer Med. 2020;9(17):6306–6321. doi:10.1002/cam4.3206</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Chen Y, Chen X, Yu H, Zhou H, Xu S. Oral Microbiota as Promising Diagnostic Biomarkers for Gastrointestinal Cancer: A Systematic Review. Onco Targets Ther. 2019;12:11131–11144. doi:10.2147/OTT.S230262</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Zhang L, Liu Y, Zheng HJ, Zhang CP. The Oral Microbiota May Have Influence on Oral Cancer. Front Cell Infect Microbiol. 2020;9:476. doi:10.3389/fcimb.2019.00476</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Li R, Xiao L, Gong T, Liu J, Li Y, Zhou X, Li Y, Zheng X. Role of oral microbiome in oral oncogenesis, tumor progression, and metastasis. Mol Oral Microbiol. 2023;38(1):9–22. doi:10.1111/omi.12403</mixed-citation></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Grigorievskaya ZV, Petukhova IN, Bagirova NS, Aginova VV, Kononets PV. Role of the microbiota in oncogenesis. Siberian journal of oncology. 2023;22(2):129–142. (In Russian)</mixed-citation><mixed-citation xml:lang="ru">Григорьевская З.В., Петухова И.Н., Багирова Н.С., Агинова В.В., Кононец П.В. Роль микробиоты в онкогенезе // Сибирский онкологический журнал. 2023;22(2):129–142</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><mixed-citation>Gu Z, Liu Y. A bibliometric and visualized in oral microbiota and cancer research from 2013 to 2022. Discov Oncol. 2024;15(1):24. doi:10.1007/s12672-024-00878-5</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Li R, Xiao L, Gong T, Liu J, Li Y, Zhou X, Li Y, Zheng X. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation. Arch Microbiol. 2021;203(1):137–152. doi:10.1007/s00203-020-02011‑w</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Senneby A, Davies JR, Svensäter G, Neilands J. Acid tolerance properties of dental biofilms in vivo. BMC Microbiol. 2017;17(1):165. doi:10.1186/s12866-017-1074-7</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Luo W, Han J, Peng X, Zhou X, Gong T, Zheng X. The role of Fusobacterium nucleatum in cancer and its implications for clinical applications. Mol Oral Microbiol. 2024;39(6):417–432. doi:10.1111/omi.12475</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Mazzio EA, Smith B, Soliman KF. Evaluation of endogenous acidic metabolic products associated with carbohydrate metabolism in tumor cells. Cell Biol Toxicol. 2010;26(3):177–188. doi:10.1007/s10565-009-9138-6</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Shrestha P, Ghoreyshi ZS, George JT. How modulation of the tumor microenvironment drives cancer immune escape dynamics. Sci Rep. 2025;15(1):7308. Published 2025 Mar 1. doi:10.1038/s41598-025-91396‑z</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Zhang L, Liu Y, Zheng HJ, Zhang CP. The Oral Microbiota May Have Influence on Oral Cancer. Front Cell Infect Microbiol. 2020;9:476. doi:10.3389/fcimb.2019.00476</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Takahashi Y, Park J, Hosomi K, Yamada T, Kobayashi A, Yamaguchi Y, et al. Analysis of oral microbiota in Japanese oral cancer patients using 16S rRNA sequencing. J Oral Biosci. 2019;61(2):120–128. doi:10.1016/j.job.2019.03.003</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Torralba MG, Aleti G, Li W, Moncera KJ, Lin YH, Yu Y, Masternak MM, Golusinski W, Golusinski P, Lamperska K, Edlund A, Freire M, Nelson KE. Oral Microbial Species and Virulence Factors Associated with Oral Squamous Cell Carcinoma. Microb Ecol. 2021;82(4):1030–1046. doi:10.1007/s00248-020-01596-5</mixed-citation></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">Avanesov AM, Gvozdikova EN. New predictive factors determining the clinical flow of oral mucositis in patients with plane-cellar cancer of oropharyngeal region. RUDN Journal of Medicine. 2018;22(1):22–28. doi: 10.22363/2313-0245-2018-22-1-22-28. (In Russian).</mixed-citation><mixed-citation xml:lang="ru">Аванесов А.М., Гвоздикова Е.Н. Прогностические факторы, определяющие клиническое течение орального мукозита у пациентов с плоскоклеточным раком орофарингеальной области // Вестник Российского университета дружбы народов. Серия: Медицина. 2018. Т. 22. № 1. C. 22–28.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">Guryanova SV. Influence of muramyl peptides on the production of chemokines, growth factors, pro-inflammatory and anti-inflammatory cytokines. RUDN Journal of Medicine. 2024;28(3):365–376. doi: 10.22363/2313-0245-2024-28-3-365-376. EDN: DJROAN. (In Russian).</mixed-citation><mixed-citation xml:lang="ru">Гурьянова С.В. Влияние мурамилпептидов на выработку хемокинов, факторов роста, провоспалительных и противовоспалительных цитокинов // Вестник Российского университета дружбы народов. Серия: Медицина. 2024. Т. 28. No 3. С. 365–376.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><mixed-citation>Tateda M, Shiga K, Saijo S, Sone M, Hori T, Yokoyama J, Matsuura K, Takasaka T, Miyagi T. Streptococcus anginosus in head and neck squamous cell carcinoma: implication in carcinogenesis. Int J Mol Med. 2000;6(6):699–703. doi:10.3892/ijmm.6.6.699</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Sasaki M, Yamaura C, Ohara-Nemoto Y, Tajika S, Kodama Y, Ohya T, Harada R, Kimura S. Streptococcus anginosus infection in oral cancer and its infection route. Oral Dis. 2005;11(3):151–156. doi:10.1111/j.1601-0825.2005.01051.x</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Asam D, Mauerer S, Spellerberg B. Streptolysin S of Streptococcus anginosus exhibits broad-range hemolytic activity. Med Microbiol Immunol. 2015;204(2):227–237. doi:10.1007/s00430-014-0363-0</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Sasaki M, Ohara-Nemoto Y, Tajika S, Kobayashi M, Yamaura C, Kimura S. Antigenic characterization of a novel Streptococcus anginosus antigen that induces nitric oxide synthesis by murine peritoneal exudate cells. J Med Microbiol. 2001;50(11):952–958. doi:10.1099/0022-1317-50-11-952</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Morita E, Narikiyo M, Yano A, Nishimura E, Igaki H, Sasaki H, Terada M, Hanada N, Kawabe R. Different frequencies of Streptococcus anginosus infection in oral cancer and esophageal cancer. Cancer Sci. 2003;94(6):492–496. doi:10.1111/j.1349–7006.2003.tb01471.x</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Narikiyo M, Tanabe C, Yamada Y, Igaki H, Tachimori Y, Kato H, Muto M, Montesano R, Sakamoto H, Nakajima Y, Sasaki H. Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer Sci. 2004;95(7):569–574. doi:10.1111/j.1349-7006.2004.tb02488.x</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Kawasaki M, Ikeda Y, Ikeda E, Takahashi M, Tanaka D, Nakajima Y, Arakawa S, Izumi Y, Miyake S. Oral infectious bacteria in dental plaque and saliva as risk factors in patients with esophageal cancer. Cancer. 2021;127(4):512–519. doi:10.1002/cncr.33316</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Gao S, Li S, Ma Z, Liang S, Shan T, Zhang M, Zhu X, et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect Agent Cancer. 2016;11:3. Published 2016 Jan 19. doi:10.1186/s13027-016-0049‑x</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Chen MF, Lu MS, Hsieh CC, Chen WC. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma. Cell Oncol (Dordr). 2021;44(2):373–384. doi:10.1007/s13402-020-00573‑x</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, Grote VA, Tjønneland A, et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut. 2013;62(12):1764–1770. doi:10.1136/gutjnl‑2012–303006</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Hu J, Han S, Chen Y, Ji Z. Variations of Tongue Coating Microbiota in Patients with Gastric Cancer. Biomed Res Int. 2015;2015:173729. doi:10.1155/2015/173729</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Wu J, Xu S, Xiang C, Cao Q, Li Q, Huang J, Shi L, Zhang J, Zhan Z. Tongue Coating Microbiota Community and Risk Effect on Gastric Cancer. J Cancer. 2018;9(21):4039–4048. doi:10.7150/jca.25280</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Huang K, Gao X, Wu L, Yan B, Wang Z, Zhang X, Peng L, Yu J, Sun G, Yang Y. Salivary Microbiota for Gastric Cancer Prediction: An Exploratory Study. Front Cell Infect Microbiol. 2021;11:640309. doi:10.3389/fcimb.2021.640309</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Wu ZF, Zou K, Xiang CJ, Jin ZJ, Ding HH, Xu S, et al. Helicobacter pylori infection is associated with the co-occurrence of bacteria in the oral cavity and the gastric mucosa. Helicobacter. 2021;26(2): e12786. doi:10.1111/hel.12786</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Hosgood HD, Cai Q, Hua X, Long J, Shi J, Wan Y, et al. Variation in oral microbiome is associated with future risk of lung cancer among never-smokers. Thorax. 2021;76(3):256–263. doi:10.1136/thoraxjnl‑2020-215542</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Shao J, Wu L, Leng WD, Fang C, Zhu YJ, Jin YH, Zeng XT. Periodontal Disease and Breast Cancer: A Meta-Analysis of 1,73,162 Participants. Front Oncol. 2018;8:601. doi:10.3389/fonc.2018.00601</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, Yajuk O, Isaacson B, Abed J, Maalouf N, Nissan A, Sandbank J, Yehuda-Shnaidman E, Ponath F, Vogel J, Mandelboim O, Granot Z, Straussman R, Bachrach G. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 2020;11(1):3259. Published 2020 Jun 26. doi:10.1038/s41467-020-16967-2</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Van der Merwe M, Van Niekerk G, Botha A, Engelbrecht AM. The onco-immunological implications of Fusobacterium nucleatum in breast cancer. Immunol Lett. 2021;232:60–66. doi:10.1016/j.imlet.2021.02.007</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Karpiński TM. Role of Oral Microbiota in Cancer Development. Microorganisms. 2019;7(1):20. doi:10.3390/microorganisms7010020</mixed-citation></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">Volkov EA, Polovets ML, Nikitin VV, Pashkova GS, Isadzhanyan KE, Popova VM, Zhilenkov EL. Efficiency of using a bacteriophage-based agent in the complex treatment of diseases of the oral mucosa. Russian Dental Journal. 2015; 19 (4):18–22. (In Russian).</mixed-citation><mixed-citation xml:lang="ru">Волков Е.А., Половец М.Л., Никитин В.В., Пашкова Г.С., Исаджанян К.Е., Попова В.М., Жиленков Е.Л. Эффективность применения средства на основе бактериофагов в комплексном лечении заболеваний слизистой оболочки полости рта // Российский стоматологический журнал. 2015. Т. 19, вып. 4.С. 18–22.</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">Volkov EA. Studying the features of microflora of patients with diseases of the oral mucosa. Assessment of the effectiveness of use of a production based on bacteriophages «phagodent» in the complex treatment of chronic aphthosic stomatitis and lichen red polish planus. Research’n Practical Medicine Journal. 2015;2(4):50–58. (In Russian).</mixed-citation><mixed-citation xml:lang="ru">Волков Е.А. Изучение особенностей микрофлоры пациентов с заболеваниями слизистой оболочки полости рта. Оценка эффективности применения средства на основе бактериофагов «фагодент» в комплексном лечении хронического афтозного стоматита и красного плоского лишая // Research’n Practical Medicine Journal. 2015. Т. 2, № 4. С. 50–58. doi:10.17709/2409-2231-2015-2-4-50-58</mixed-citation></citation-alternatives></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">Uryadnikova VA, Ippolitov YuA, Aleshina EO, Mikhailova SA, Kuralesina VP, Ryzhkova YuA, Klepalko EA. Modern concepts for the treatment of inflammatory diseases of the oral cavity using bacteriophages. Modern science: current problems of theory and practice. Series: Natural and technical sciences.2024; 4(2): 156–159. (In Russian).</mixed-citation><mixed-citation xml:lang="ru">Урядникова В.А., Ипполитов Ю.А., Алешина Е.О., Михайлова С.А., Куралесина В.П., Рыжкова Ю.А., Клепалко Е.А. Современные концепции лечения воспалительных заболеваний полости рта с применением бактериофагов // Современная наука: актуальные проблемы теории и практики. Серия: Естественные и технические науки. 2024. Т. 4, вып. 2. С. 156–159.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
